Craig-Hallum analyst Matt Hewitt initiated coverage of Clover Health (CLOV) with a Buy rating and $6 price target
Invest with Confidence:
- Follow TipRanks' Top Wall Street Analysts to uncover their success rate and average return.
- Join thousands of data-driven investors – Build your Smart Portfolio for personalized insights.